Researcher profile

Sanjay Kumar

1. Dange P, Pandit S, Jadhav DA, Shanmugam P, Gupta PK, Kumar S, Kumar M, Yang JH, Bhatia SK. Recent developments in Microbial Electrolysis Cells-based Simultaneous Biohydrogen Production and Wastewater Treatment. Sustainability, (Accepted) Impact Factor-3.2 2. Gupta PK, Saraff M, Gahtori R, Negi N, Tripathi SK, Kumar J, Kumar S, Aldhayan SA, Dhanasekaran S, Abomughaid MM, Dua K, Gundamaraju R, Ojha S, Ruokolainen J, Jha NK, Kesari RK, (2021). Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development. Pharmaceuticals. (In press), Impact Factor-5.8 3. Zhang J, Kumar S, Jayachandran M, Wang S, Wilson E, Lieske J (2021) Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers. BMC Nephrol. 22(1):204. Impact Factor-2.3 4. Meeran MF Nagoor, Mamoudh H, Azimullah S, Sharma S, Kumar S, Goyal SN, Ojha S (2021). Nerolidol, a natural sesquiterpene found in the essential oils of aromatic plants attenuates doxorubicin induced chronic cardiotoxicity in rats. J Agric Food Chem. 69(26):7334-7343. Impact Factor 5.2. 5. Nagoor MFN, Hayate J, Kumar S , Goyal SN, Jha NK, Ojha S (2021). Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon. (2):e05990. 6. Jayachandran M, Yuzhakov SV, Kumar S, Milliner SD, Rule AD, Lieske JC (2020). Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones. Orphanet J Rare Dis. 15(1):319. Impact Factor-4.2 7. Meeran N, Sharma C, Goyal S, Kumar S, Ojha S (2020).CB2 receptor-selective agonists as candidates for targeting infection, inflammation and immunity in SARS-CoV-2 infections. Drug Dev Res. 82(1):7-11. Impact Factor-4.2. 8. Gonzalez Guerrico AM, Lieske J, Klee G, Kumar S, Wright AM, Lopez-Baez V, Bobart S, Shevell D, Maldonado M, Troost JP, Hogan MC (2020). Urinary CD80 discriminates among glomerular disease types and reflects disease activity. Kidney Int Rep. 5(11):2021-2031. Impact Factor- 4.2. 9. Ramakrishnan V, Miller K, Haug J, Kimlinger K, Kumar S, Gonsalves W, Rajkumar VS, Kumar S (2019). HDAC inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma. Haematologica. 104(10):2061-2074. Impact factor-9.9. 10. Kourelis T, Murray DL, DasariS, Kumar S, Barnidge D, Madden B, Arendt B, Milani P, Merlini G, Alvarado MR, Kyle RA, Dispenzieri A (2018). MASS‐FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.Am J Hematol. 93(11):E368-E370. Impact Factor- 10.1 11. Kumar S, Murray D, Dasari S, Milani P, Barnidge D, Madden B, Kourelis T, Arendt B, Merlini G, Alvarado M, Dispenzieri A (2019). Assay to rapid screening for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis. Leukemia. (1):254-257. Impact Factor-11.5 12. Kumar S*,Tinson A, Mulligan BP, Ojha S (2016). Gelatin Binding Proteins in Reproductive Physiology. Indian J Microbiol. 56(4):383-393 (*Corresponding Author).Impact Factor-2.4. 13. Tomar AK, Kumar S, Chhillar S, Kumaresan A, Singh S, Yadav S (2016). Human Serum Albumin and Prolactin Inducible Protein complex enhances sperm capacitation in vitro. J Protein and proteomics. 7(2):107-113. 14. Kumar S, Tomar AK, Singh S, Gill K, Dey S, Singh S, Yadav S (2014). Heparin binding carboxypeptidase E protein exhibits antibacterial activity in human semen. Int J Biol. Macromol. 64:319-27. Impact Factor-6.9 15. Binita K, Kumar S, Sharma VK, Sharma V, Yadav S (2014). Proteomic Identification of Syzygiumcumini Seed Extracts by MALDI-TOF/MS. Appl. Biochem. Biotechnol. 172(4):2091-105. Impact Factor-2.9 16. Kumar S, Sharma VK, Singh S, Hariprasad GR, Mal G, Srinivasan A, Yadav S (2013). Proteomic identification of camel seminal plasma: Purification of β-Nerve Growth Factor. Anim. Reprod Sci. 136(4):289-295. Impact Factor-2.2 17. Kumar S, Tomar AK, Singh S, Saraswat M, Singh S, Singh TP, Yadav S (2012). Human serum albumin as a new interacting partner of prolactin inducible protein in human seminal plasma. Int. J Biol. Macromol. 50 (2):317-322. Impact Factor-6.9 18. Yadav VK, Kumar V, Chhikara N, Kumar S, Manral P, Kashav T, Saini S, Srinivasan A, Singh S, Singh TP, Yadav S (2011).Purification and characterization of a native zinc- binding high molecular weight multiprotein complex from human seminal plasma. J Sep Sci. 34 (9):1076-83. Impact Factor-3.6 19. Tomar AK, Saraswat M, Chhikara N, Kumar S, Yadav VK, Sooch BS, Singh TP, Yadav S (2010). Differential proteomics of sperm: insights, challenges and future prospects. Biomark Med. 4 (6):905-10. Impact Factor-2.8.